147 related articles for article (PubMed ID: 38887281)
1. A local drug delivery system prolongs graft survival by dampening T cell infiltration and neutrophil extracellular trap formation in vascularized composite allografts.
Arenas Hoyos I; Helmer A; Yerly A; Lese I; Hirsiger S; Zhang L; Casoni D; Garcia L; Petrucci M; Hammer SE; Duckova T; Banz Y; Montani M; Constantinescu M; Vögelin E; Bordon G; Aleandri S; Prost JC; Taddeo A; Luciani P; Rieben R; Sorvillo N; Olariu R
Front Immunol; 2024; 15():1387945. PubMed ID: 38887281
[TBL] [Abstract][Full Text] [Related]
2. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.
Fries CA; Lawson SD; Wang LC; Slaughter KV; Vemula PK; Dhayani A; Joshi N; Karp JM; Rickard RF; Gorantla VS; Davis MR
PLoS One; 2019; 14(1):e0210914. PubMed ID: 30677062
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Biodistribution of Tacrolimus after Topical Administration: Implications for Vascularized Composite Allotransplantation.
Feturi FG; Schnider JT; Fanzio PM; Erbas VE; Oksuz S; Sahin H; Dong L; Unadkat JM; Spiess AM; Plock JA; Solari MG; Gorantla VS; Venkataramanan R
Pharm Res; 2020 Oct; 37(11):222. PubMed ID: 33067715
[TBL] [Abstract][Full Text] [Related]
4. Local Injections of Tacrolimus-loaded Hydrogel Reduce Systemic Immunosuppression-related Toxicity in Vascularized Composite Allotransplantation.
Dzhonova DV; Olariu R; Leckenby J; Banz Y; Prost JC; Dhayani A; Vemula PK; Voegelin E; Taddeo A; Rieben R
Transplantation; 2018 Oct; 102(10):1684-1694. PubMed ID: 29794937
[TBL] [Abstract][Full Text] [Related]
5. Topical Tacrolimus and Mycophenolic Acid Therapy Synergizes with Low Dose Systemic Immunosuppression to Sustain Vascularized Composite Allograft Survival.
Feturi FG; Zhang W; Erbas VE; Dong L; Sahin H; Zhang Z; Oksuz S; Spiess AM; Solari MG; Venkataramanan R; Gorantla VS
J Pharm Sci; 2024 Jun; 113(6):1607-1615. PubMed ID: 38309457
[TBL] [Abstract][Full Text] [Related]
6. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity.
Feturi FG; Unadkat JV; Zhang W; Hag ME; Wang Y; Komatsu C; Grybowski D; Zhang Z; Erbas V; Sahin H; Mcclaine S; Oksuz S; Plock J; Gorantla VS; Washington KM; Solari MG; Venkataramanan R; Spiess AM
Pharm Res; 2022 Sep; 39(9):2179-2190. PubMed ID: 35915321
[TBL] [Abstract][Full Text] [Related]
8. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
[TBL] [Abstract][Full Text] [Related]
9. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome profiling of immune rejection mechanisms in a porcine vascularized composite allotransplantation model.
Zhang L; Arenas Hoyos I; Helmer A; Banz Y; Zubler C; Lese I; Hirsiger S; Constantinescu M; Rieben R; Gultom M; Olariu R
Front Immunol; 2024; 15():1390163. PubMed ID: 38840906
[TBL] [Abstract][Full Text] [Related]
11. Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?
Cetrulo CL; Torabi R; Scalea JR; Shimizu A; Leto Barone AA; Gillon BC; Tasaki M; Leonard DA; Cormack TA; Villani V; Randolph MA; Sachs DH; Yamada K
Transplantation; 2013 Dec; 96(11):966-74. PubMed ID: 24056624
[TBL] [Abstract][Full Text] [Related]
12. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model.
Gama AR; Ng ZY; Shanmugarajah K; Mastroianni M; Randolph MA; Lellouch AG; Kohn J; Cetrulo CL
J Burn Care Res; 2020 Nov; 41(6):1172-1178. PubMed ID: 32352521
[TBL] [Abstract][Full Text] [Related]
13. Local immunosuppression in vascularized composite allotransplantation (VCA): A systematic review.
Safi AF; Kauke M; Nelms L; Palmer WJ; Tchiloemba B; Kollar B; Haug V; Pomahač B
J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):327-335. PubMed ID: 33229219
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Tacrolimus on Tissue-Specific, Protein-Level Inflammatory Networks in Vascularized Composite Allotransplantation.
Aral AM; Zamora R; Barclay D; Yin J; El-Dehaibi F; Erbas VE; Dong L; Zhang Z; Sahin H; Gorantla VS; Vodovotz Y
Front Immunol; 2021; 12():591154. PubMed ID: 34017323
[TBL] [Abstract][Full Text] [Related]
15. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
16. Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports.
Van Dieren L; Tawa P; Coppens M; Naenen L; Dogan O; Quisenaerts T; Lancia HH; Oubari H; Dabi Y; De Fré M; Thiessen Ef F; Cetrulo CL; Lellouch AG
J Surg Res; 2024 Jun; 298():137-148. PubMed ID: 38603944
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.
Sutter D; Dzhonova DV; Prost JC; Bovet C; Banz Y; Rahnfeld L; Leroux JC; Rieben R; Vögelin E; Plock JA; Luciani P; Taddeo A; Schnider JT
Sci Rep; 2019 Jun; 9(1):9269. PubMed ID: 31239498
[TBL] [Abstract][Full Text] [Related]
18. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
[TBL] [Abstract][Full Text] [Related]
19. Mimicking Clinical Rejection Patterns in a Rat Osteomyocutaneous Flap Model of Vascularized Composite Allotransplantation.
Beare JE; Fleissig Y; Kelm NQ; Reed RM; LeBlanc AJ; Hoying JB; Kaufman CL
J Surg Res; 2024 Mar; 295():28-40. PubMed ID: 37979234
[TBL] [Abstract][Full Text] [Related]
20. Exosomes from donor-derived adipose mesenchymal stem cells prolong the survival of vascularized composite allografts.
Chen Z; Xue S; Zhang S; Cheng K; Ye Q
J Cell Physiol; 2021 Aug; 236(8):5895-5905. PubMed ID: 33452713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
